Memory CD8 + T cells confer efficient and long-lasting immunity against secondary pathogen exposure 1,2 . Events during primary exposure (priming) affect the quality of the initial effector and subsequent memory cytotoxic T lymphocyte (CTL) responses. Unless environmental cues (for example, CD4 + T cell help or inflammation) are present, T cell receptor (TCR) signaling does not result in effective activation of CD8 + T cells [3] [4] [5] [6] [7] . Furthermore, in the absence of CD4 + T cell help, the resultant CD4-unhelped CD8 + T cells do not differentiate into sustainable memory cells 4 .
Memory CD8 + T cells confer efficient and long-lasting immunity against secondary pathogen exposure 1,2 . Events during primary exposure (priming) affect the quality of the initial effector and subsequent memory cytotoxic T lymphocyte (CTL) responses. Unless environmental cues (for example, CD4 + T cell help or inflammation) are present, T cell receptor (TCR) signaling does not result in effective activation of CD8 + T cells [3] [4] [5] [6] [7] . Furthermore, in the absence of CD4 + T cell help, the resultant CD4-unhelped CD8 + T cells do not differentiate into sustainable memory cells 4 .
NKG2D is expressed on natural killer (NK) cells and on activated CD8 + T cells and binds to the ligands retinoic acid early inducible protein 1ε (Rae-1ε), MULT-1 and H60 in mice [8] [9] [10] [11] [12] [13] , and MICA/B and ULBP in humans 14, 15 . NKG2D engagement on CD8 + T cells contributes to TCR signaling, co-stimulation and amplification of T cell signals and recognition of stress-induced proteins [16] [17] [18] . In addition to this canonical function, NKG2D also has a role in CD8 + T cell-mediated autoimmune pathophysiology 19 . Therefore, strategies augmenting NKG2D engagement on CD8 + T cells and harnessing its new functions identified here may result in the rescue of CD4-unhelped CD8 + T cell responses.
RESULTS
NKG2D co-stimulation rescues CD8 + T cell memory expansion CD8 + T cells that do not receive CD4 + T cell help during priming undergo impaired memory-recall responses 6, 20 . Because NKG2D engagement on CD8 + T cells contributes to co-stimulation 16, 17 , we hypothesized that increased NKG2D engagement by Rae-1ε on antigen-presenting cells (APCs) during priming would rescue memoryrecall CD4-unhelped CD8 + T cell expansion. We used skin gene gun vaccination 21 (in vivo biolistic transfection) to co-deliver DNA plasmids encoding chicken ovalbumin (OVA) and Rae-1ε (OVA + Rae-1ε), OVA and empty vector (OVA + empty), or both empty vectors (empty + empty) to skin APCs. Using a Rae-1ε-GFP fusion vector 22 , we verified that skin DNA delivery resulted in elevated expression of Rae-1ε protein on draining lymph node APCs (Supplementary Fig. 1 ).
Next, we assessed the effects of OVA + Rae-1ε vaccination (the NKG2D co-stimulation regimen) on CD8 + T cell memory-recall responses. C57BL/6 mice received gene gun vaccinations three times (days 0, 5 and 10) with or without antibody-mediated CD4 depletion (days −2, 0, 5 and 10), were rested for 4 weeks during memory formation and then received one memory boost vaccination (OVA only without Rae-1ε and without CD4 depletion) on day 38 (Fig. 1a) . OVAspecific CD8 + T cell numbers were determined by OVA-tetramer staining of splenocytes ( Fig. 1b and Supplementary Fig. 2 ) and confirmed in the draining inguinal lymph node (Supplementary Fig. 3 ). We observed similar post-contraction numbers (day 38, before boost) of OVA-specific CD8 + T cells in all groups (Fig. 1b,c) . Remarkably, the NKG2D co-stimulation regimen at priming resulted in complete rescue of CD4-unhelped OVA-specific CD8 + T cell expansion at the memory-recall phase (Fig. 1c,d and Supplementary Fig. 3b ).
NKG2D co-stimulation rescues CD8 + T cell memory function
Given the ability of the NKG2D co-stimulation regimen to augment memory-recall expansion, we hypothesized that such engagement during priming may rescue memory cytolytic molecule and cytokine production by CD4-unhelped CD8 + T cells. Notably, upon memory boost with OVA only, CD4-unhelped CD8 + T cells that received the NKG2D co-stimulation regimen during priming showed complete rescue of granzyme B, interleukin-2 (IL-2) and interferon-γ (IFN-γ) production (Fig. 2a) . The effect of the memory boost vaccination (that is, a single vaccination) on naive cells on day 38 was negligible ( Supplementary Fig. 4) .
To further investigate NKG2D-mediated rescue of CD4-unhelped CD8 + T cell memory-recall responses, we examined antigen-specific target lysis ability (Fig. 2b) . CD4 depletion at priming significantly weakened CD8 + T cell memory-recall lytic activity (CTL lysis) (Fig. 2c,d) . Notably, administration of either Rae-1ε (to C57BL/6 mice) or H60 (NKG2D ligand in B6BCF1 mice) during priming resulted in complete rescue of CD4-unhelped CD8 + T cell memory CTL lysis (Fig. 2d) . As CD4 + T cells were present during the boost vaccination, we next analyzed memory-recall responses in their absence. CD4 depletion during the memory boost resulted in decreased memory-recall CTL lysis in all groups (Supplementary Fig. 5 ). Although we observed the greatest decrease in the group primed without the NKG2D costimulation regimen and depleted of CD4 + T cells both during priming and memory boost, we nevertheless observed rescue of CTL lysis with the NKG2D co-stimulation regimen (Supplementary Fig. 5 ).
NKG2D is necessary on CD8 + T cells for memory rescue
To demonstrate that the observed rescue of memory-recall responses is dependent on NKG2D and, specifically, on CD8 + T cell NKG2D engagement, we conducted a series of experiments. First, we blocked NKG2D with antibody during priming and observed decreased memory CTL lysis (Fig. 3a) . Vaccination of NKG2D-blocked, CD4-depleted mice with OVA + Rae-1ε did not rescue CD4-unhelped CD8 + T cell lysis (Fig. 3a) .
Second, given that NK and NKT cells express NKG2D, we determined their role in NKG2D-mediated CD8 + T cell rescue. We depleted C57BL/6 mice of NK1.1 + cells 23 and transferred Thy1.1-marked OT-I CD8 + T cells into them. This design allowed induction of detectable OVA-specific responses with a single vaccination, thereby abrogating the need for further NK1.1 depletions and thus avoiding depletion of activated NK1.1-expressing OT-I CD8 + T cells. In this experiment, priming of CD8 + T cells occurred after NK1.1 depletion antibody had cleared (data not shown) and before NK and NKT cells had returned (Fig. 3b) . Memory-recall OVA-specific CD8 + T cell lysis was not negatively affected by NK1.1 depletion during priming, and CD4-unhelped CD8 + T cell lysis was rescued by the NKG2D engagement regimen (Fig. 3c) .
Lastly, to demonstrate that NKG2D-mediated rescue is the result of NKG2D engagement on CD8 + T cells, we vaccinated CD45.1 + C57BL/6 wild-type (WT) mice that received adoptively transferred CD45.1 − CD8 + T cells from NKG2D-deficient (Klrk1 −/− ) 24 (Fig. 3d) or CD45.1 − WT mice. Compared to transferred WT CD8 + T cells, transferred NKG2D-deficient CD8 + T cells showed decreased memory-recall expansion (Fig. 3e) . OVA + Rae-1ε vaccination at priming did not rescue memory-recall expansion (Fig. 3e) of CD4-unhelped NKG2D-deficient transferred CD8 + T cells but did rescue expansion of CD4-unhelped WT transferred CD8 + T cells (Fig. 3e) and endogenous CD8 + T cells in both hosts (data not shown).
NKG2D-mediated rescue is not independent of IL-15
Roles for IL-15 in NKG2D upregulation 25 and signaling 26 and rescue of CD4-unhelped CD8 + T cells 27 Fig. 6a ). Fig. 6b ) and CTL lysis ( Supplementary Fig. 6c ) of OVA-specific CD8 + T cells were greatly reduced in IL-15-deficient (Il15 −/− ) mice in comparison to WT mice. The NKG2D co-stimulation regimen was partially able to rescue CD4-unhelped CD8 + T cell responses in the absence of IL-15 to the level observed without CD4 depletion but was unable to rescue to the level observed in WT mice ( Supplementary  Fig. 6b,c) . Thus, NKG2D-mediated rescue of CD8 + T cells is not independent of IL-15.
Memory phase expansion (Supplementary

NKG2D co-stimulation does not rescue effector responses
We next investigated CD8 + T cell responses at the effector phase. We observed a decreased expansion of CD4-unhelped OVA-specific CD8 + T cells at the effector phase (day 15), which, unexpectedly, was not augmented by the NKG2D co-stimulation regimen ( Fig. 1b and Supplementary Fig. 7) .
We observed an increase in CD8 + T cell effector phase granzyme B production ( Supplementary Fig. 8a ) and target lysis ( Supplementary Fig. 8b ) in nondepleted mice receiving the NKG2D co-stimulation regimen as opposed to mice depleted of CD4 + cells. However, lack of CD4 help resulted in unrescued minimal target lysis in mice receiving OVA + empty, OVA + Rae-1ε and OVA + H60 vaccination ( Supplementary Fig. 8c,d ).
NKG2D engagement results in JNK2-mediated T-bet suppression CD4-unhelped CD8 + T cells have greater T-bet protein expression than their CD4-helped counterparts 28 , and T-bet expression during the effector phase distinguishes short-lived effector cells (SLECs; T-bet hi ) from memory precursor effector cells (MPECs; T-bet lo ) [28] [29] [30] [31] .
To determine whether effector phase T-bet expression correlates with NKG2D-mediated rescue of CD4-unhelped CD8 + T cell memoryrecall responses, we determined T-bet expression in OVA-specific CD8 + T cells. In the context of CD4 help, OVA-specific CD8 + T cells consistently had low T-bet expression throughout the effector and memory phases (Fig. 4a-c) . Conversely, CD4-unhelped OVA-specific CD8 + T cells primed without the NKG2D co-stimulation regimen had significantly increased expression of T-bet ( Fig. 4a-c) . Notably, T-bet expression levels in CD4-unhelped CD8 + T cells were reduced (45%) with the NKG2D co-stimulation regimen, were similar to T-bet levels of CD4-helped CD8 + T cells throughout the effector phase and were lower during the memory phase ( Fig. 4a-c) . Corroborating these findings, T-bet levels were higher in NKG2D-deficient versus WT OVA-specific CD8 + T cells transferred into a WT host, especially under CD4-depletion conditions (Fig. 4d) , and were higher when compared to those in endogenous CD8 + T cells (Supplementary Fig. 9a ). Likewise, T-bet expression in OVA-specific CD8 + T cells was elevated in IL-15-deficient versus WT hosts, especially under CD4-depletion conditions (Fig. 4e) , and only partially repressed by the NKG2D co-stimulation regimen ( Fig. 4e and Supplementary Fig. 9b) .
Studies have shown that co-stimulation of CD8 + T cells results in activation of the c-Jun N-terminal kinase 2 (JNK2) pathway 32 and that JNK2-knockout mice have increased levels of T-bet expression 33 . In our studies, in vitro-activated NKG2D-deficient CD8 + T cells expressed higher T-bet (Fig. 5a ) and lower phosphorylated JNK2 (pJNK2) levels (Fig. 5b) compared to WT counterparts. Additionally, WT CD8 + T cells similarly activated in the presence of NKG2D-blocking antibody showed lower pJNK2 levels (Fig. 5b) . On the basis of these observations Number of cells and evidence that NKG2D modulates JNK signaling 34, 35 , we hypothesized that NKG2D signaling represses T-bet via JNK2. JNK2 pathway inhibition of in vitro OT-I CD8 + T cell activation with OVA 257-264 peptide-loaded EL4 mouse lymphoma cells expressing Rae-1ε resulted in a significant increase in T-bet to levels resembling OT-I CD8 + T cells activated without NKG2D co-stimulation (Fig. 5c ).
NKG2D confers protection in CD4-dependent infections
To address the condition in which CD4 + T cell counts in vivo remain continuously low or absent, we characterized the ability of NKG2D to rescue CD8 + T cell responses under continuous CD4 + cell depletion via CD4-specific antibody administered every 5 d (days −2 to 43) (Fig. 6a) . Under these conditions, CD8 + T cell memory expansion was significantly reduced (Fig. 6b) and T-bet expression further increased (Fig. 6c) compared to CD4 depletion only during priming (Figs. 1 and 4) . However, CD8 + T cells primed with the NKG2D co-stimulation regimen and continuously depleted of CD4 + T cells showed rescued total memory-recall responses (Fig. 6c) as well as memory-recall responses on a per-cell basis in an ex vivo CTL assay where OVA-tetramer + CD8 + T cell numbers were equalized from the vaccination conditions (Supplementary Fig. 10 ).
To assess functional responses in an in vivo pathogenic model, we used a lethal influenza-PR/8 infection model, in which the virus expresses OVA and clearance via CD8 + cells is CD4 dependent (Fig. 6d) . Absence of the NKG2D co-stimulation regimen and presence of continuous CD4 depletion in C57BL/6 mice resulted in decreased CD8 + T cell memory-recall responses (Fig. 6e) and low survival (~20%) (Fig. 6f) after influenza-PR/8 infection. In contrast, the NKG2D co-stimulation regimen resulted in augmented CD8 + T cell memory-recall responses and survival (Fig. 6e,f) . Further, CD8 + T cells from mice lacking NKG2D expression were unable to respond to influenza-PR/8 challenge in vivo despite receiving OVA + Rae-1ε vaccination during priming (Fig. 6e) .
To further assess the role of NKG2D co-stimulation in a pathogenic model where chronic CD4 deficiency has a major role in disease progression, we determined the response of HIV-specific CD8 + T cells from chronic HIV-positive donors, whose lack of CD4 + T cell help leads to CD4-unhelped CD8 + T cells 36 , and compared these with CD8 + T cells from long-term nonprogressor (LTNP) HIV-positive donors whose maintained CD4 + T cell help leads to potent anti-HIV npg CD8 + T cell responses 37 (Supplementary Table 1) . To replicate the conditions used in our in vivo mouse studies, we stimulated donor peripheral blood mononuclear cells (PBMCs) with pooled HIV peptides in the presence or absence of exogenous NKG2D agonist antibody, rested them for 2 d and re-stimulated them with pooled HIV peptides (without NKG2D agonist antibody) (Fig. 6g) . As in the mouse models, NKG2D co-stimulation of human CD8 + T cells from chronic HIV donors lowered T-bet expression (Fig. 6h) and rescued their recall ability to produce granzyme B, IL-2 and IFN-γ (Fig. 6i) and proliferate (Fig. 6j) . Further, the phenotype and functionality of NKG2D-rescued recall CD8 + T cell responses from chronically infected HIV-positive donors resembled those associated with CD8 + T cell responses from HIV-positive LTNPs (Fig. 6h-j) .
DISCUSSION
We demonstrate that augmented NKG2D engagement on CD8 + T cells rescues CD4-unhelped CD8 + T cell memory-recall responses. Contrary to our expectations, the NKG2D co-stimulation regimen did not rescue CD4-unhelped effector responses. This paradoxical finding raises the question of how memory-recall responses can be rescued in the absence of effector responses. We discovered that, through augmentation of JNK2 phosphorylation, increased NKG2D co-stimulation results in CD4-unhelped CD8 + T effector cells with reduced expression of T-bet, a transcription factor that at low expression drives formation of effector cells with increased memory potential [28] [29] [30] [31] . This leads us to propose that the effector-phase responses and memory potential of CD8 + T cells may be dictated by separate signals and, furthermore, that NKG2D co-stimulation provides CD8 + T cells with memory potential programming for conversion to potent memory CD8 + T cells even in the absence of primary effector responses.
Similar to the impaired effector cytolytic responses of CD4-unhelped CD8 + T cells in our study, previous studies 5, 38 have shown comparable (that is, nearly absent) CD4-helpless effector responses on day 14. However, some studies have shown that CD4-unhelped CD8 + T cell effector responses are typically less affected and that memoryrecall responses are greatly impaired 4, 6, 7, 39, 40 . This difference may be attributed to the level of inflammation-mediated response present during the effector phase. In the studies conducted using infection models, CD4-unhelped CD8 + T cell responses may have arisen from infection-associated inflammation signals. In our study, skin gene gun delivery causes limited inflammation 41 and thus aids in deconstructing effector response mechanisms.
Despite the absence of effector responses from CD4-unhelped CD8 + T cells vaccinated without the NKG2D co-stimulation regimen, we observed memory responses, albeit defective ones. These preserved memory responses are attributable to the return of CD4 + T cell help during memory-phase boost vaccination. Recent studies support the notion that CD4-unhelped responses can be rescued in the memory phase 5, 42 . Notably, even with continuous CD4 depletion throughout both the effector and memory phases, the NKG2D co-stimulation regimen still rescued CD8 + T cell memory responses.
Studies have shown that IL-15 can induce NKG2D expression on CD8 + T cells 25 and that IL-15 is necessary for NKG2D signaling 26 . In our study, NKG2D-mediated rescue in CD4-unhelped CD8 + T cells was partially dependent on IL-15. These data may provide the mechanism by which IL-15 has been shown to aid in CD4-unhelped memory response rescue 27 . IL-2, a cytokine augmented in our studies with increased NKG2D engagement, has been reported to compensate for the lack of IL-15 (ref. 43 ). These results may warrant future investigation in determining whether the partial rescue observed in IL-15-deficient mice may be mediated by NKG2D signaling through alternative molecular pathways 44 or whether other common γ-chain cytokines compensate for the lack of IL-15 in this situation.
Even under deleterious conditions in an in vivo pathogenic model of lethal influenza-PR/8 infection during continuous immunocompromising CD4 depletion, augmented NKG2D co-stimulation provided mice with rescued memory-recall CD8 + T cells and a high rate of survival. These findings raise the possibility of including an NKG2D co-stimulation regimen in human vaccination protocols. Specifically in the context of influenza vaccines, which in a nonadjuvant form do not drive strong CD4 + T cell responses 45 , these data suggest a potential enhancement, via the NKG2D co-stimulation regimen, of the effectiveness of CD8 + T cell responses. Additionally, such an NKG2D co-stimulation regimen may avoid vaccine side effects attributable to robust CD4 + T cell activation in the presence of strong adjuvants 46 .
Finally, we demonstrate that the NKG2D co-stimulation regimen observations equally pertain to a human disease system in which CD4 + T cells are progressively depleted by HIV, resulting in CD8 + T cells that are characteristically CD4 unhelped 47 . Whereas increased T-bet expression by Nef peptide-stimulated, IFN-γ-producing CD8 + T cells from HIV elite controllers (a subset of LTNPs) has been reported 48 , our study demonstrates that NKG2D co-stimulation reduced T-bet expression of Gag tetramer-and Pol tetramer-specific CD8 + T cells from chronically infected HIV donors and rescued their ability to acquire cytolytic potential. Furthermore, such NKG2D co-stimulation rescued ex vivo CD8 + T cell responses from chronically infected HIVpositive donors to resemble the phenotype and functionality associated with HIV-positive LTNP CD8 + T cell responses. Augmented NKG2D co-stimulation may have a role in improving CD8 + T cell responses against HIV itself and against AIDS-associated pathogens.
This work demonstrates that NKG2D co-stimulatory signaling during priming may have therapeutic value, specifically in the development of optimal memory-recall responses and the reversal of the impotent state of CD4-unhelped CD8 + T cells. These findings may be useful in T cell-based vaccine design and adoptive T cell therapy, where potent effector and memory formation are vital for successful eradication of acute and recurrent disease, especially in situations where CD4 + T cells are depleted as a result of the disease (for example, HIV/AIDS), exhausted or suppressed as a sequela of the given pathology (for example, chronic infection or cancer) or therapeutically depleted to remove immune suppression (for example, cancer). In such situations, delivery of NKG2D ligand may be a feasible substitute for CD4 + T cell help.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemedicine/. 
